Skip to main content
Premium Trial:

Request an Annual Quote

Itching to Sell

The New York Times has a piece up today on biotech companies that are contending with a sluggish market for psoriasis drugs. Despite having biologics that work, firms like Amgen, Genentech, and Biogen Idec have faced drooping sales for their respective psoriasis drugs. The article reports that the low sales can be traced to price barriers, as well as reluctance on the parts of doctors and insurers to prescribe and cover the treatments. This might be an early lesson for firms hoping to get genomics-based drugs on the market in coming years. We’re looking at you, RNAi.


The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.